Sanofi, 10% Owner at REGENERON PHARMACEUTICALS INC (REGN), sold 209,104 shares at $406.68 ($85.0M) on 2018-09-06, disclosed to the SEC on 2018-09-10.
Open-market sale of $85.0M REGN by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $406.68 | 104,552 | $42.5M | 50.0% |
| 2 | $406.68 | 104,552 | $42.5M | 50.0% |
| Total | $406.68 avg | 209,104 | $85.0M | 100% |
| Filing → |
| ICVX | BUY | 2021-08-02 | $1.0M | — | Filing → |
| INZY | BUY | 2020-07-29 | $1.3M | — | Filing → |
| REGN | SELL | 2020-06-11 | $143.7M | — | Filing → |